Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling Pathway

P-glycoprotein (known as ABCB1 transporter) expression in myeloid blasts of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) leads to the commonly observed multidrug resistance. Overexpression of latrophilin-1 was detected in leukemic cells from AML patients. In a previous study, we sh...

Full description

Bibliographic Details
Main Authors: Zuzana Kocibalova, Martina Guzyova, Ivana Borovska, Lucia Messingerova, Lucia Copakova, Zdena Sulova, Albert Breier
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/14/3629
_version_ 1797527466384818176
author Zuzana Kocibalova
Martina Guzyova
Ivana Borovska
Lucia Messingerova
Lucia Copakova
Zdena Sulova
Albert Breier
author_facet Zuzana Kocibalova
Martina Guzyova
Ivana Borovska
Lucia Messingerova
Lucia Copakova
Zdena Sulova
Albert Breier
author_sort Zuzana Kocibalova
collection DOAJ
description P-glycoprotein (known as ABCB1 transporter) expression in myeloid blasts of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) leads to the commonly observed multidrug resistance. Overexpression of latrophilin-1 was detected in leukemic cells from AML patients. In a previous study, we showed that ABCB1 overexpression is associated with decreased latrophilin-1 expression in MOLM-13/VCR and SKM-1/VCR AML cell variants derived from MOLM-13 and SKM-1 cells by vincristine selection/adaptation. In the present study, we found that if ABCB1 overexpression occurs in myeloid blasts of newly diagnosed MDS patients, latrophilin-1 expression is attenuated. Latrophilin-1 may initiate TIM-3- and galectin-9-mediated immune escape. We demonstrated changes in the expression of both proteins by comparing ABCB1-positive cell variants (MOLM-13/VCR, SKM-1/VCR) with their ABCB1-negative counterparts. Galectin-9 was present in our cell lines in eight protein isoforms for which we identified the respective transcription variants resulting from alternative splicing, and we verified their structure by sequencing. The isoform profile of galectin-9 was different between ABCB1-positive and ABCB1-negative cell variants. The interaction partner of galectin-9 is CD44, and its expression was altered in the ABCB1-positive variants MOLM-13/VCR and SKM-1/VCR compared to their ABCB1-negative counterparts.
first_indexed 2024-03-10T09:43:14Z
format Article
id doaj.art-8303f006d9b54e0da612d33a8f35ac1b
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T09:43:14Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-8303f006d9b54e0da612d33a8f35ac1b2023-11-22T03:26:34ZengMDPI AGCancers2072-66942021-07-011314362910.3390/cancers13143629Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling PathwayZuzana Kocibalova0Martina Guzyova1Ivana Borovska2Lucia Messingerova3Lucia Copakova4Zdena Sulova5Albert Breier6Faculty of Chemical and Food Technology, Institute of Biochemistry and Microbiology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, SlovakiaFaculty of Chemical and Food Technology, Institute of Biochemistry and Microbiology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, SlovakiaDepartment of Biochemistry and Cytochemistry, Institute of Molecular Physiology and Genetics, Centre of Bioscences SAS, Slovak Academy of Sciences, Dúbravská cesta 9, 840 05 Bratislava, SlovakiaFaculty of Chemical and Food Technology, Institute of Biochemistry and Microbiology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, SlovakiaNational Cancer Institute, Klenová 1, 833 10 Bratislava, SlovakiaDepartment of Biochemistry and Cytochemistry, Institute of Molecular Physiology and Genetics, Centre of Bioscences SAS, Slovak Academy of Sciences, Dúbravská cesta 9, 840 05 Bratislava, SlovakiaFaculty of Chemical and Food Technology, Institute of Biochemistry and Microbiology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, SlovakiaP-glycoprotein (known as ABCB1 transporter) expression in myeloid blasts of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) leads to the commonly observed multidrug resistance. Overexpression of latrophilin-1 was detected in leukemic cells from AML patients. In a previous study, we showed that ABCB1 overexpression is associated with decreased latrophilin-1 expression in MOLM-13/VCR and SKM-1/VCR AML cell variants derived from MOLM-13 and SKM-1 cells by vincristine selection/adaptation. In the present study, we found that if ABCB1 overexpression occurs in myeloid blasts of newly diagnosed MDS patients, latrophilin-1 expression is attenuated. Latrophilin-1 may initiate TIM-3- and galectin-9-mediated immune escape. We demonstrated changes in the expression of both proteins by comparing ABCB1-positive cell variants (MOLM-13/VCR, SKM-1/VCR) with their ABCB1-negative counterparts. Galectin-9 was present in our cell lines in eight protein isoforms for which we identified the respective transcription variants resulting from alternative splicing, and we verified their structure by sequencing. The isoform profile of galectin-9 was different between ABCB1-positive and ABCB1-negative cell variants. The interaction partner of galectin-9 is CD44, and its expression was altered in the ABCB1-positive variants MOLM-13/VCR and SKM-1/VCR compared to their ABCB1-negative counterparts.https://www.mdpi.com/2072-6694/13/14/3629latrophilin-1TIM-3galectin-9ABCB1CD44acute myeloid leukemia
spellingShingle Zuzana Kocibalova
Martina Guzyova
Ivana Borovska
Lucia Messingerova
Lucia Copakova
Zdena Sulova
Albert Breier
Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling Pathway
Cancers
latrophilin-1
TIM-3
galectin-9
ABCB1
CD44
acute myeloid leukemia
title Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling Pathway
title_full Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling Pathway
title_fullStr Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling Pathway
title_full_unstemmed Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling Pathway
title_short Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling Pathway
title_sort development of multidrug resistance in acute myeloid leukemia is associated with alterations of the lphn1 gal 9 tim 3 signaling pathway
topic latrophilin-1
TIM-3
galectin-9
ABCB1
CD44
acute myeloid leukemia
url https://www.mdpi.com/2072-6694/13/14/3629
work_keys_str_mv AT zuzanakocibalova developmentofmultidrugresistanceinacutemyeloidleukemiaisassociatedwithalterationsofthelphn1gal9tim3signalingpathway
AT martinaguzyova developmentofmultidrugresistanceinacutemyeloidleukemiaisassociatedwithalterationsofthelphn1gal9tim3signalingpathway
AT ivanaborovska developmentofmultidrugresistanceinacutemyeloidleukemiaisassociatedwithalterationsofthelphn1gal9tim3signalingpathway
AT luciamessingerova developmentofmultidrugresistanceinacutemyeloidleukemiaisassociatedwithalterationsofthelphn1gal9tim3signalingpathway
AT luciacopakova developmentofmultidrugresistanceinacutemyeloidleukemiaisassociatedwithalterationsofthelphn1gal9tim3signalingpathway
AT zdenasulova developmentofmultidrugresistanceinacutemyeloidleukemiaisassociatedwithalterationsofthelphn1gal9tim3signalingpathway
AT albertbreier developmentofmultidrugresistanceinacutemyeloidleukemiaisassociatedwithalterationsofthelphn1gal9tim3signalingpathway